Global Information
회사소개 | 문의 | 비교리스트

세계의 방사성 피부염 치료 시장(2019-2023년)

Global Radiodermatitis Treatment Market 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 05월 상품 코드 843053
페이지 정보 영문 133 Pages
가격
US $ 2,500 ₩ 2,971,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,565,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,753,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,942,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 방사성 피부염 치료 시장(2019-2023년) Global Radiodermatitis Treatment Market 2019-2023
발행일 : 2019년 05월 페이지 정보 : 영문 133 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 방사성 피부염 치료 시장은 공공/민간 의료기관 증가 등에 의해 성장이 촉진되고 있습니다. 2023년까지 시장은 4% 이상의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 방사성 피부염(Radiodermatitis) 치료 시장을 조사했으며, 시장 개요, 제품·유통채널·지역별 시장 규모 추이와 예측, 시장 성장요인 및 과제 분석, 시장 동향, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

시장 개요

목차

제1장 주요 요약

제2장 보고서의 범위

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 시장 세분화 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모
  • 시장 규모 예측

제5장 질병 개요

제6장 Five Forces 분석

  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 진출기업의 위협
  • 대체품의 위협
  • 경쟁 기업간 경쟁 관계
  • 시장 현황

제7장 파이프라인 분석

제8장 시장 세분화 : 제품별

  • 시장 세분화 : 제품별
  • 시장 비교 : 제품별
  • 국소 치료제
  • 드레싱
  • 경구약
  • 시장 기회 : 제품별

제9장 고객 상황

제10장 시장 세분화 : 유통채널별

제11장 지역 상황

  • 시장 세분화 : 지역별
  • 시장 세분화 : 지역별
  • 아시아
  • 북미
  • 유럽
  • 기타 지역
  • 주요 국가
  • 시장 기회

제12장 의사결정 프레임워크

제13장 성장요인과 과제

  • 시장 성장요인
  • 시장의 과제

제14장 시장 동향

제15장 벤더 상황

  • 개요
  • 파괴적 혁신
  • 경쟁 시나리오

제16장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • 3M
  • Acelity LP Inc.
  • ConvaTec Group Plc
  • Molnlycke Health Care AB
  • Smith & Nephew Plc

제17장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제18장 TECHNAVIO에 대해

LSH 19.05.23

About this market

Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio. Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period. Technavio's analysts have predicted that the radiodermatitis treatment market will register a CAGR of over 4% by 2023.

Market Overview

The rising number of public and private healthcare organizations

Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.

Advent of novel radiation equipment with fewer side-effects

The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.

For the detailed list of factors that will drive and challenge the growth of the radiodermatitis treatment market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: DISEASE OVERVIEW

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Topical - Market size and forecast 2018-2023
  • Dressings - Market size and forecast 2018-2023
  • Oral - Market size and forecast 2018-2023
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

PART 11: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 3M
  • Acelity LP Inc.
  • ConvaTec Group Plc
  • Molnlycke Health Care AB
  • Smith & Nephew Plc

PART 17: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 18: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Factors driving global radiodermatitis treatment market 2019-2023
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Types of radiodermatitis
  • Exhibit 11: Epidemiology statistics of cancer in the US
  • Exhibit 12: Five forces analysis 2018
  • Exhibit 13: Five forces analysis 2023
  • Exhibit 14: Bargaining power of buyers
  • Exhibit 15: Bargaining power of suppliers
  • Exhibit 16: Threat of new entrants
  • Exhibit 17: Threat of substitutes
  • Exhibit 18: Threat of rivalry
  • Exhibit 19: Market condition - Five forces 2018
  • Exhibit 20: Pipeline landscape
  • Exhibit 21: Some of the drugs investigated for radiodermatitis
  • Exhibit 22: Product - Market share 2018-2023 (%)
  • Exhibit 23: Comparison by product
  • Exhibit 24: Topical - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Topical - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Dressings - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Dressings - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Oral - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: Oral - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Market opportunity by product
  • Exhibit 31: Customer landscape
  • Exhibit 32: Market share by distribution channel, 2018
  • Exhibit 33: Market share by geography 2018-2023 (%)
  • Exhibit 34: Geographic comparison
  • Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Incidence rate of lung cancer
  • Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Top 3 countries in Asia
  • Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: Key industry trends in North America
  • Exhibit 41: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: Top 3 countries in North America
  • Exhibit 43: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 44: Incidence rate of cancer in Germany, 2012
  • Exhibit 45: Projected incidence rate of cancer in Germany, 2030
  • Exhibit 46: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 47: Top 3 countries in Europe
  • Exhibit 48: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 49: Facts about cancer in Australia
  • Exhibit 50: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 51: Top 3 countries in ROW
  • Exhibit 52: Key leading countries
  • Exhibit 53: Market opportunity
  • Exhibit 54: Cancer prevalence in US in 2015
  • Exhibit 55: Cancer prevalence in England in 2016
  • Exhibit 56: Types of external beam radiation therapy
  • Exhibit 57: Impact of drivers and challenges
  • Exhibit 58: CDC statistics for obesity and diabetes
  • Exhibit 59: Vendor landscape
  • Exhibit 60: Landscape disruption
  • Exhibit 61: Vendors covered
  • Exhibit 62: Vendor classification
  • Exhibit 63: Market positioning of vendors
  • Exhibit 64: 3M - Vendor overview
  • Exhibit 65: 3M - Business segments
  • Exhibit 66: 3M - Organizational developments
  • Exhibit 67: 3M - Geographic focus
  • Exhibit 68: 3M - Segment focus
  • Exhibit 69: 3M - Key offerings
  • Exhibit 70: 3M - Key customers
  • Exhibit 71: Acelity LP Inc. - Vendor overview
  • Exhibit 72: Acelity LP Inc. - Organizational developments
  • Exhibit 73: Acelity LP Inc. - Key offerings
  • Exhibit 74: Acelity LP Inc. - Key customers
  • Exhibit 75: ConvaTec Group Plc - Vendor overview
  • Exhibit 76: ConvaTec Group Plc - Product segments
  • Exhibit 77: ConvaTec Group Plc - Organizational developments
  • Exhibit 78: ConvaTec Group Plc - Geographic focus
  • Exhibit 79: ConvaTec Group Plc - Segment focus
  • Exhibit 80: ConvaTec Group Plc - Key offerings
  • Exhibit 81: ConvaTec Group Plc - Key customers
  • Exhibit 82: Molnlycke Health Care AB - Vendor overview
  • Exhibit 83: Molnlycke Health Care AB - Product segments
  • Exhibit 84: Molnlycke Health Care AB - Organizational developments
  • Exhibit 85: Molnlycke Health Care AB - Geographic focus
  • Exhibit 86: Molnlycke Health Care AB - Segment focus
  • Exhibit 87: Molnlycke Health Care AB - Key offerings
  • Exhibit 88: Molnlycke Health Care AB - Key customers
  • Exhibit 89: Smith & Nephew Plc - Vendor overview
  • Exhibit 90: Smith & Nephew Plc - Business segments
  • Exhibit 91: Smith & Nephew Plc - Organizational developments
  • Exhibit 92: Smith & Nephew Plc - Geographic focus
  • Exhibit 93: Smith & Nephew Plc - Segment focus
  • Exhibit 94: Smith & Nephew Plc - Key offerings
  • Exhibit 95: Smith & Nephew Plc - Key customers
  • Exhibit 96: Validation techniques employed for market sizing
  • Exhibit 97: Definition of market positioning of vendors
Back to Top
전화 문의
F A Q